跳到主要导航 跳到搜索 跳到主要内容

GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1

  • Yi Zhong
  • , Zheng Wang
  • , Baojin Fu
  • , Fan Pan
  • , Shinichi Yachida
  • , Mousumi Dhara
  • , Emilia Albesiano
  • , Li Li
  • , Yoshiki Naito
  • , Felip Vilardell
  • , Christopher Cummings
  • , Paola Martinelli
  • , Ang Li
  • , Raluca Yonescu
  • , Qingyong Ma
  • , Constance A. Griffin
  • , Francisco X. Real
  • , Christine A. Iacobuzio-Donahue
  • Johns Hopkins University
  • Xi'an Jiaotong University
  • Hospital Universitari Arnau de Vilanova de Lleida
  • University of Colorado Anschutz Medical Campus
  • Spanish National Cancer Research Centre (CNIO)
  • Pompeu Fabra University

科研成果: 期刊稿件文章同行评审

85 引用 (Scopus)

摘要

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease characterized by late diagnosis and treatment resistance. Recurrent genetic alterations in defined genes in association with perturbations of developmental cell signaling pathways have been associated with PDAC development and progression. Here, we show that GATA6 contributes to pancreatic carcinogenesis during the temporal progression of pancreatic intraepithelial neoplasia by virtue of Wnt pathway activation. GATA6 is recurrently amplified by both quantitative-PCR and fluorescent in-situ hybridization in human pancreatic intraepithelial neoplasia and in PDAC tissues, and GATA6 copy number is significantly correlated with overall patient survival. Forced overexpression of GATA6 in cancer cell lines enhanced cell proliferation and colony formation in soft agar in vitro and growth in vivo, as well as increased Wnt signaling. By contrast siRNA mediated knockdown of GATA6 led to corresponding decreases in these same parameters. The effects of GATA6 were found to be due to its ability to bind DNA, as forced overexpression of a DNA-binding mutant of GATA6 had no effects on cell growth in vitro or in vivo, nor did they affect Wnt signaling levels in these same cells. A microarray analysis revealed the Wnt antagonist Dickopf-1 (DKK1) as a dysregulated gene in association with GATA6 knockdown, and direct binding of GATA6 to the DKK1 promoter was confirmed by chromatin immunoprecipitation and electrophoretic mobility shift assays. Transient transfection of GATA6, but not mutant GATA6, into cancer cell lines led to decreased DKK1 mRNA expression and secretion of DKK1 protein into culture media. Forced overexpression of DKK1 antagonized the effects of GATA6 on Wnt signaling in pancreatic cancer cells. These findings illustrate that one mechanism by which GATA6 promotes pancreatic carcinogenesis is by virtue of its activation of canonical Wnt signaling via regulation of DKK1.

源语言英语
文章编号e22129
期刊PLoS ONE
6
7
DOI
出版状态已出版 - 2011

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1' 的科研主题。它们共同构成独一无二的指纹。

引用此